Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

ConditionsMalignant Digestive System Neoplasm Malignant Female Reproductive System Neoplasm Malignant Genitourinary System Neoplasm

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorWake Forest University Health Sciences

About this trial

This study evaluates the use of extended venous thromboembolism prophylaxis (ePPx) following abdominopelvic cancer surgery within the NCI Community Oncology Research Program (NCORP) network, targeting surgeons and surgical advanced practice providers (APPs).

Eligibility criteria

Qualifiers

None

Disqualifiers

N/A

Trial design

Treatments tested in this trial

Non-Interventional Study
Non-Interventional Study
Non-Interventional Study

Treatment groups

500 Participants

are divided into 3 treatment groups

Locations

Puerto Rico

San Patricio Medflix00968, Guaynabo Puerto Rico

United States

Arkansas

Mercy Hospital Fort Smith72903, Fort Smith United States

Delaware

Christiana Care Health System-Christiana Hospital19718, Newark United States

Helen F Graham Cancer Center19713, Newark United States

Sponsors and collaborators

Wake Forest University Health Sciences

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Source ClinicalTrials.gov